Financial PerformanceRevenues were $5MM above forecast on higher licensing revenue in biorefining, largely related to $8MM of non-cash revenue related to LNZA's previously disclosed increased share in LanzaJet.
Revenue GuidanceLNZA guided 4Q24 revenue to ~$70MM, bringing FY24 revenues to $108MM, above the prior guide of $90-105MM.
Strategic PartnershipsLNZA is expanding its strategy to partnering with capital providers to get projects to FID, a useful shift following limited project sanctions this year.